^
BIOMARKER:
ERCC2 E606Q
i
Other names: ERCC2, EM9, MAG, MGC102762, MGC126218, MGC126219, TFIIH, XPD, Excision repair cross-complementation group 2
Entrez ID:
Related biomarkers:
›
ERCC2 E606Q
|
Urothelial Cancer
|
ERCC2 E606Q
|
Urothelial Cancer
|
cisplatin Sensitive: C4 – Case Studies
|
cisplatin Sensitive: C4 – Case Studies
|
ERCC2 E606Q
|
Urothelial Cancer
|
ERCC2 E606Q
|
Urothelial Cancer
|
gemcitabine Sensitive: C4 – Case Studies
|
gemcitabine Sensitive: C4 – Case Studies
|
ERCC2 E606Q
|
Urothelial Cancer
|
ERCC2 E606Q
|
Urothelial Cancer
|
carboplatin Sensitive: C4 – Case Studies
|
carboplatin Sensitive: C4 – Case Studies
|
ERCC2 E606Q
|
Bladder Cancer
|
ERCC2 E606Q
|
Bladder Cancer
|
cisplatin + gemcitabine Sensitive: C4 – Case Studies
|
cisplatin + gemcitabine Sensitive: C4 – Case Studies
|
ERCC2 E606Q
|
Bladder Cancer
|
ERCC2 E606Q
|
Bladder Cancer
|
carboplatin + gemcitabine Sensitive: C4 – Case Studies
|
carboplatin + gemcitabine Sensitive: C4 – Case Studies
|
